Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 202280

Expand all

ESCITALOPRAM OXALATE (ESCITALOPRAM OXALATE)
EQ 5MG BASE
Marketing Status: Prescription

Active Ingredient: ESCITALOPRAM OXALATE
Proprietary Name: ESCITALOPRAM OXALATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202280
Product Number: 001
Approval Date: Sep 12, 2012
Applicant Holder Full Name: JUBILANT CADISTA PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ESCITALOPRAM OXALATE (ESCITALOPRAM OXALATE)
EQ 10MG BASE
Marketing Status: Prescription

Active Ingredient: ESCITALOPRAM OXALATE
Proprietary Name: ESCITALOPRAM OXALATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202280
Product Number: 002
Approval Date: Sep 12, 2012
Applicant Holder Full Name: JUBILANT CADISTA PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ESCITALOPRAM OXALATE (ESCITALOPRAM OXALATE)
EQ 20MG BASE
Marketing Status: Prescription

Active Ingredient: ESCITALOPRAM OXALATE
Proprietary Name: ESCITALOPRAM OXALATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 20MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202280
Product Number: 003
Approval Date: Sep 12, 2012
Applicant Holder Full Name: JUBILANT CADISTA PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information